Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 30.79
- Piotroski Score 2.00
- Grade Buy
- Symbol (TYRA)
- Company Tyra Biosciences, Inc.
- Price $16.72
- Changes Percentage (1.82%)
- Change $0.3
- Day Low $16.00
- Day High $16.85
- Year High $29.60
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/05/2024
- Fiscal Year End N/A
- Average Stock Price Target $32.00
- High Stock Price Target $33.00
- Low Stock Price Target $25.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.69
- Trailing P/E Ratio -11.7
- Forward P/E Ratio -11.7
- P/E Growth -11.7
- Net Income $-69,134,000
Income Statement
Quarterly
Annual
Latest News of TYRA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Chief Financial Officer of Tyra Biosciences Alan Fuhrman Buys 284% More Shares
Tyra Biosciences' CFO, Alan Fuhrman, bought $152k worth of TYRA stock at $16 per share, increasing his holdings by 284%. This insider purchase signals optimism. With 4....
By Yahoo! Finance | 2 days ago -
Man forced wife and children to work on farm with 'tyranny' of abuse, Victorian supreme court hears
A father is accused of forcing his family into servitude through physical, verbal, and emotional abuse on a farm. He pleads not guilty to 12 charges. Prosecutors allege he used fear and violence to co...
By The Guardian | 1 week ago -
Tyra Banks Teases Outside the Box Idea for Life-Size 3 with Lindsay Lohan
Tyra Banks is considering a new Life-Size movie with Lindsay Lohan returning as a doll. Banks shared her idea on The Drew Barrymore Show, sparking excitement among fans. Lohan has yet to confirm her i...
By PEOPLE.com | 1 week ago
